Renaissance Technologies’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
153,539
-191,661
| -56% | -$1.32M | ﹤0.01% | 2490 |
|
|
2025
Q1 | $1.83M | Buy |
345,200
+206,100
| +148% | +$1.09M | ﹤0.01% | 2060 |
|
|
2024
Q4 | $1.64M | Buy |
139,100
+123,100
| +769% | +$1.45M | ﹤0.01% | 2176 |
|
|
2024
Q3 | $330K | Buy |
+16,000
| New | +$330K | ﹤0.01% | 2945 |
|
|
2024
Q2 | – | Sell |
-10,123
| Closed | -$397K | – | 3557 |
|
|
2024
Q1 | $397K | Buy |
+10,123
| New | +$397K | ﹤0.01% | 2965 |
|
|
2023
Q1 | – | Sell |
-3,423
| Closed | -$11K | – | 4029 |
|
|
2022
Q4 | $11K | Sell |
3,423
-22,928
| -87% | -$73.7K | ﹤0.01% | 4029 |
|
|
2022
Q3 | $130K | Sell |
26,351
-27,878
| -51% | -$138K | ﹤0.01% | 3510 |
|
|
2022
Q2 | $410K | Buy |
54,229
+15,656
| +41% | +$118K | ﹤0.01% | 3274 |
|
|
2022
Q1 | $615K | Buy |
38,573
+30,383
| +371% | +$484K | ﹤0.01% | 3049 |
|
|
2021
Q4 | $151K | Buy |
+8,190
| New | +$151K | ﹤0.01% | 3603 |
|
|
2021
Q1 | – | Sell |
-32,070
| Closed | -$1.2M | – | 3365 |
|
|
2020
Q4 | $1.2M | Buy |
32,070
+832
| +3% | +$31.2K | ﹤0.01% | 2412 |
|
|
2020
Q3 | $1.69M | Buy |
31,238
+24,851
| +389% | +$1.34M | ﹤0.01% | 2235 |
|
|
2020
Q2 | $1.61M | Buy |
+6,387
| New | +$1.61M | ﹤0.01% | 2300 |
|
|
2018
Q3 | – | Sell |
-5,561
| Closed | -$842K | – | 3369 |
|
|
2018
Q2 | $842K | Buy |
+5,561
| New | +$842K | ﹤0.01% | 2664 |
|
|
2016
Q4 | – | Sell |
-6,307
| Closed | -$1.29M | – | 3271 |
|
|
2016
Q3 | $1.29M | Buy |
6,307
+1,410
| +29% | +$287K | ﹤0.01% | 2437 |
|
|
2016
Q2 | $439K | Buy |
4,897
+3,010
| +160% | +$270K | ﹤0.01% | 2840 |
|
|
2016
Q1 | $102K | Buy |
1,887
+1,094
| +138% | +$59.1K | ﹤0.01% | 3210 |
|
|
2015
Q4 | $39K | Buy |
+793
| New | +$39K | ﹤0.01% | 3197 |
|